|
Drug Enhancement Company of America |
|
Roger D. Griggs is an entrepreneur and businessman. Mr. Griggs began his professional career as a teacher and football coach in northern Indiana. His pharmaceutical career started as field sales representative for Lederle Laboratories and was promoted several management positions.
In 1990, Mr. Griggs founded Richwood Pharmaceuticals and rapidly grew the company until it merged with Shire Pharmaceutical Group plc, of Andover, England in 1997. In February of 1998, Mr. Griggs resigned his position as President of Shire US and has since founded numerous businesses including Union Springs LLC (investment organization), Integrity Pharmaceuticals, Xanodyne Pharmaceuticals, PediaMed Pharmaceuticals, and DECA.
He is a member of the American Marketing Association, the Licensing Executive Society, Tri-Ed Business Development Council, American Venture Capital Association, the Greater Cincinnati Venture Capital Association, the Indiana Healthcare Forum, Queen City Angels and Florence Baptist Church. In 1997, Mr. Griggs was chosen as the "Entrepreneur of the Year" recipient for the Greater Cincinnati area in the field of Life Sciences. He was later selected a national finalist for that category in Palm Springs, California and finished in the top three for the nation. Also in 1998 he was chosen as a charter member of the Blue Chip Venture Partners Hall of Fame.
He has a B.S. degree in secondary education from Indiana State and a master's degree in secondary education from Indiana University. |
|
Roger Griggs Biography |
|
Significant Acquisitions, Developments and Mergers |
|
Product Status ADDERALL Commercialization, Shire plc DextroStat Commericalization, Shire plc WISP Clinical Trials, PediaMed MDDP Clinical Trials, PediaMed Lucidex Commercialization, Xanodyne
Significant Agreements: Wyeth (3 products acquired) Probst (Acquisition) Allergan (Co-promotions) Connectics (Acquisition) DuPont (Co-promotion) Schering-Plough (Co-promotions) Rexar Pharmacal (Acquisition) AAI Pharma (Acquisition) Shire Pharmaceuticals (Merger) |